Immediate Impact
3 by Nobel laureates 8 from Science/Nature 95 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
Works of R. Asola being referenced
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| R. Asola | 516 | 277 | 208 | 16 | 683 | |
| D F Hayes | 451 | 322 | 152 | 11 | 743 | |
| L. D. Ziegler | 520 | 321 | 174 | 18 | 739 | |
| Melissa Brammer | 574 | 146 | 346 | 36 | 732 | |
| G. Piot | 459 | 157 | 143 | 21 | 682 | |
| Rémy Largillier | 461 | 309 | 139 | 31 | 702 | |
| W. E. C. Allt | 196 | 235 | 160 | 11 | 674 | |
| B. Lisboa | 465 | 366 | 95 | 23 | 770 | |
| A. Galid | 507 | 206 | 164 | 26 | 734 | |
| Robert W. Frelick | 497 | 417 | 158 | 20 | 831 | |
| R. Kokko | 644 | 406 | 160 | 22 | 819 |
All Works
Loading papers...